FdaApplication
NDA 022026
Identifiers
- fda_app_no: NDA022026
Properties
| Property | Value |
|---|---|
| applicant_name | SYNTHON PHARMACEUTICALS INC |
| application_type | NDA |
| approval_date | 2007-09-27 |
Products (3)
| Product | Active ingredient | Strength | Dosage form |
|---|---|---|---|
| AMLODIPINE BESYLATE | AMLODIPINE BESYLATE | EQ 5MG BASE | TABLET, ORALLY DISINTEGRATING;ORAL |
| AMLODIPINE BESYLATE | AMLODIPINE BESYLATE | EQ 2.5MG BASE | TABLET, ORALLY DISINTEGRATING;ORAL |
| AMLODIPINE BESYLATE | AMLODIPINE BESYLATE | EQ 10MG BASE | TABLET, ORALLY DISINTEGRATING;ORAL |
3 products